Evaluating the Prognostic Nutritional Index in Renal Cell Carcinoma Patients: A Comprehensive Systematic Review and Meta-Analysis Update - Scorecard - MDSpire
Advertisement
Evaluating the Prognostic Nutritional Index in Renal Cell Carcinoma Patients: A Comprehensive Systematic Review and Meta-Analysis Update
Clinical Scorecard: Evaluating the Prognostic Nutritional Index in Renal Cell Carcinoma Patients: A Comprehensive Systematic Review and Meta-Analysis Update
At a Glance
Category
Detail
Condition
Key Mechanisms
Prognostic Nutritional Index (PNI) reflects nutritional and immune status, influencing tumor progression and survival outcomes.
Target Population
Care Setting
Key Highlights
PNI is calculated using serum albumin and lymphocyte count.
Low PNI values correlate with poor prognosis in RCC, with specific cutoff values ranging from 40.23 to 51.62.
Existing studies show variability in PNI cutoff values, impacting clinical application.
Recent meta-analysis includes more studies and larger sample sizes.
PNI may aid in risk stratification and personalized treatment, particularly in targeted therapies.
Guideline-Based Recommendations
Diagnosis
Management
Consider PNI in treatment planning for RCC patients, especially those receiving targeted therapies and immunotherapy.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with Renal Cell Carcinoma undergoing treatment.
PNI may provide insights into survival outcomes and treatment responses.
Clinical Best Practices
Utilize PNI as a complementary prognostic tool in RCC, supported by recent studies.
Incorporate nutritional assessments in the management of RCC patients, referencing relevant literature.
